![CME Programme CSHK mw_menu_data_5564_56eb2b174e5e3.jpg](https://cshk.org/site/CSHK/upload/mw_menu_data/file/mw_menu_data_5564_56eb2b174e5e3.jpg)
CME Programme
-
Non-Regular Activities
Latest advancement in the management of Urothelial CarcinomaDate: 02/08/2022 Enquiries: Hong Kong Society of Uro-Oncology; Merck Pharmaceutical; Pfizer CME Points Awarded: 2 points
CME Programme
Date: | 02/08/2022 |
Enquiries: | Hong Kong Society of Uro-Oncology; Merck Pharmaceutical; Pfizer |
CME Points Awarded: | 2 points |